lobbying_activities: 3188753

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3188753	86db1246-13bb-4dcc-a2de-c474d050545e	Q2	GOVERNMENT COUNSEL, LLC	401105070	APOTEX CORPORATION	2024	second_quarter	MAN	Federal policy relating to strengthening domestic generic production and market access barriers for generic pharmaceuticals.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2024-07-11T12:35:48-04:00